This post is sponsored by IMARC Research, Inc. Since the August 2011 release of the draft guidance document by the FDA on a risk-based approach to monitoring, there has been a lot of buzz in the ...
In this free webinar, gain insight into the key elements to reduce risk for clinical trials. Attendees will learn how Independent Review and Data Analytics in eCOA strengthen endpoint integrity and ...
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "GCP Risk Management and Risk-Based Monitoring" training has been added to ResearchAndMarkets.com's offering. Good Clinical Practice (GCP) is a set of ...
Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft guidance related to the risk-based monitoring ...
Following the release of five guidances to broaden cancer clinical trial eligibility earlier this week, the US Food and Drug Administration (FDA) is out with draft guidance Thursday on the risk-based ...
Risk monitoring is the ongoing process of identifying, understanding, assessing, monitoring, managing, and mitigating risks that could adversely affect an organization's operations, value, assets and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results